These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 14727262)

  • 1. von Willebrand factor-cleaving protease (ADAMTS-13) activity determination in the diagnosis of thrombotic microangiopathies: the Swiss experience.
    Kremer Hovinga JA; Studt JD; Alberio L; Lämmle B
    Semin Hematol; 2004 Jan; 41(1):75-82. PubMed ID: 14727262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Von Willebrand factor-cleaving protease (ADAMTS-13) activity in thrombotic microangiopathies: diagnostic experience 2001/2002 of a single research laboratory.
    Studt JD; Kremer Hovinga JA; Alberio L; Bianchi V; Lämmle B
    Swiss Med Wkly; 2003 Jun; 133(23-24):325-32. PubMed ID: 12923683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
    Furlan M; Lämmle B
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombotic thrombocytopenic purpura and other thrombotic microangiopathic hemolytic anemias: diagnosis and classification.
    Shenkman B; Einav Y
    Autoimmun Rev; 2014; 13(4-5):584-6. PubMed ID: 24418304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?
    Shibagaki Y; Fujita T
    Hypertens Res; 2005 Jan; 28(1):89-95. PubMed ID: 15969259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in thrombotic thrombocytopenic purpura.
    Sadler JE; Moake JL; Miyata T; George JN
    Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombotic thrombocytopenic purpura.
    Lämmle B; Kremer Hovinga JA; Alberio L
    J Thromb Haemost; 2005 Aug; 3(8):1663-75. PubMed ID: 16102032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathophysiology of thrombotic microangiopathies: current understanding].
    Coppo P; Veyradier A; Durey MA; Fremeaux-Bacchi V; Scrobohaci ML; Amesland F; Bussel A
    Ann Med Interne (Paris); 2002 May; 153(3):153-66. PubMed ID: 12218898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe deficiency of the specific von Willebrand factor-cleaving protease (ADAMTS 13) activity in a subgroup of children with atypical hemolytic uremic syndrome.
    Veyradier A; Obert B; Haddad E; Cloarec S; Nivet H; Foulard M; Lesure F; Delattre P; Lakhdari M; Meyer D; Girma JP; Loirat C
    J Pediatr; 2003 Mar; 142(3):310-7. PubMed ID: 12640381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency.
    Terrell DR; Williams LA; Vesely SK; Lämmle B; Hovinga JA; George JN
    J Thromb Haemost; 2005 Jul; 3(7):1432-6. PubMed ID: 15978100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The von Willebrand factor-cleaving protease (ADAMTS-13) and the diagnosis of thrombotic thrombocytopenic purpura (TTP).
    Kremer Hovinga JA; Studt JD; Lämmle B
    Pathophysiol Haemost Thromb; 2003 Sep-2004 Dec; 33(5-6):417-21. PubMed ID: 15692254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombotic thrombocytopenic purpura: pathogenesis, diagnosis and potential novel therapeutics.
    Saha M; McDaniel JK; Zheng XL
    J Thromb Haemost; 2017 Oct; 15(10):1889-1900. PubMed ID: 28662310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura.
    Furlan M
    Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):243-55. PubMed ID: 15030284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome (TTP-HUS) Registry: a community perspective of patients with clinically diagnosed TTP-HUS.
    George JN; Vesely SK; Terrell DR
    Semin Hematol; 2004 Jan; 41(1):60-7. PubMed ID: 14727260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelets: thrombotic thrombocytopenic purpura.
    George JN; Sadler JE; Lämmle B
    Hematology Am Soc Hematol Educ Program; 2002; ():315-34. PubMed ID: 12446430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases.
    Veyradier A; Obert B; Houllier A; Meyer D; Girma JP
    Blood; 2001 Sep; 98(6):1765-72. PubMed ID: 11535510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autosomal recessive inheritance of von Willebrand factor-cleaving protease deficiency.
    te Loo DM; Levtchenko E; Furlan M; Roosendaal GP; van den Heuvel LP
    Pediatr Nephrol; 2000 Aug; 14(8-9):762-5. PubMed ID: 10955922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura.
    Moake JL
    Semin Hematol; 2004 Jan; 41(1):4-14. PubMed ID: 14727254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two novel ADAMTS13 gene mutations in thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome (TTP/HUS).
    Licht C; Stapenhorst L; Simon T; Budde U; Schneppenheim R; Hoppe B
    Kidney Int; 2004 Sep; 66(3):955-8. PubMed ID: 15327386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mild to moderate reduction of a von Willebrand factor cleaving protease (ADAMTS-13) in pregnant women with HELLP microangiopathic syndrome.
    Lattuada A; Rossi E; Calzarossa C; Candolfi R; Mannucci PM
    Haematologica; 2003 Sep; 88(9):1029-34. PubMed ID: 12969811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.